Competitive and Market Trend Analysis of Pharmaceutical Excipients Industry Through 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Will the Pharmaceutical Excipients Market Evolve in Terms of Growth and Size by 2029?
The market for drugs treating anemia and other blood disorders has experienced impressive expansion over recent years. This growth trend is set to continue, with the market expected to rise from $11.81 billion in 2024 to $12.46 billion in 2025, showcasing a compound annual growth rate (CAGR) of 5.5%. Factors such as disease prevalence, worldwide health campaigns, an aging population base, innovations within the pharmaceutical sector, and heightened patient awareness have been instrumental in driving growth during the historical period.
The market size for drugs treating anemia and other blood disorders is predicted to experience a substantial rise in the upcoming years. It is projected to expand to “$15.82 billion by 2029, with a compound annual growth rate (CAGR) of 6.1%. The expected growth in the forecast period can be ascribed to the rise of emerging markets, global demographic changes, and economic variables. Key trends anticipated during the forecast period encompass research and development efforts, advancements in technology, the advent of biologics and targeted therapies, gene therapies, telemedicine and remote patient monitoring, provisions for orphan drugs, as well as the impact of mergers and acquisitions.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2465&type=smp
What factors are expected to fuel Pharmaceutical Excipients market growth in the coming years?
The growth of the pharmaceutical excipients market has been fueled by a global rise in the sales of generic drugs. These drugs serve as substitutes for their branded counterparts, maintaining the same dosage, strength, safety, method of administration, and quality. As reported by the India Brand Equity Foundation (IBEF), India reigns as the primary supplier of generic medicines worldwide, with 20% of global generic drug exports originating from the country. In addition, 300 generic drug approvals in the USA were granted to Indian pharmaceutical corporations. The swell in demand for generic drugs is a significant driving force behind the expansion of the pharmaceutical excipients market.
The anemia and other blood disorder drugs market covered in this report is segmented –
1) By Type: Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia
2) By Route of Administration: Oral, Injectable
3) By Distribution Channel: Hospitals Pharmacy, Online Pharmacy, Pharmacy
Subsegments:
1) By Iron Deficiency Anemia: Oral Iron Supplements, Injectable Iron Supplements, Iron Fortified Foods
2) By Chronic Kidney Disease Anemia: Erythropoiesis-Stimulating Agents (ESAs), Iron Supplements, Blood Transfusion
3) By Sickle Cell Anemia: Hydroxyurea, Blood Transfusions, Gene Therapy, Pain Management Drugs
4) By Aplastic Anemia: Immunosuppressive Therapy, Stem Cell Transplantation, Erythropoiesis-Stimulating Agents (ESAs)
What Upcoming Trends Are Expected To Impact The Pharmaceutical Excipients Market Globally?
Firms in the anemia and other blood disorder drugs sector are partnering with government entities to aid in the innovation and distribution of a particular type of medication, sharing resources, expertise, and expenses. These partnerships can also mitigate issues relating to license expiration and strict regulatory scenarios for these companies. For instance, in March 2023, Disc Medicine publicized a partnership with the National Institutes of Health (NIH) and the National Heart, Lung, and Blood Institute (NHLBI) to conduct Phase 1/2 and Phase 2 clinical trials of biopterin in Diamond-Blackfan Anemia (DBA) patients, as well as to treat adult patients with iron deficiency anemia. The research will be administered and financed by the NIH through a cooperative research and development agreement (CRADA).
What Are The Most Active Companies In The Pharmaceutical Excipients Market Today?
Major companies operating in the anemia and other blood disorder drugs market include Amgen Inc, GlaxoSmithKline plc, Akebia Therapeutics Inc., Bayer AG, Pfizer Inc, F. Hoffmann-La Roche Ltd., Merck Sharp & Dohme Corp., Novartis AG, Global Blood Therapeutics Inc., GlycoMimetics Inc., Eli Lilly and Company, FibroGen Inc., bluebird bio Inc., Acceleron Pharma Inc., AMAG Pharmaceuticals Inc., Pieris Pharmaceuticals Inc., Vifor Pharma Management Ltd., Sanofi S.A., Allergan U.S. Inc., Meda Consumer Healthcare Inc., AbbVie Inc., Johnson & Johnson, Daiichi Sankyo Company Limited, Galenica Ltd., Pharmacosmos A/S, Emmaus Medical Inc., Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company, Merck & Co. Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., uniQure N.V., Rubius Therapeutics Inc., BioMarin Pharmaceutical Inc., Grifols S.A., Orchard Therapeutics plc
Which Regional Markets Are Attracting The Most Investment In Pharmaceutical Excipients?
North America was the largest region in the anemia and other blood disorder drugs market in 2024. Middle East is expected to be the fastest-growing region in the anemia and other blood disorder drugs market during the forecast period. The regions covered in the anemia and other blood disorder drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=2465&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
